Publication: An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
…
Description
57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL
Keywords
Citation
WoS Q
Scopus Q
Source
Volume
126
Issue
23